Ignite Creation Date:
2024-05-05 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00127270
Status:
COMPLETED
Last Update Posted:
2008-01-24
First Post:
2005-06-30
Brief Title:
Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder
Sponsor:
Novartis
Organization:
Novartis
Organization Data
Organization:
Novartis
Class:
INDUSTRY
Study ID:
CDAR328AUS01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novartis
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
External Affairs
Old Organization:
Novartis
Collaborators
| Name | Class |
|---|---|
| Procter and Gamble | INDUSTRY |